相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Protection against increased intestinal permeability and bacterial translocation induced by intestinal obstruction in mice treated with viable and heat-killed Saccharomyces boulardii
Simone V. Generoso et al.
EUROPEAN JOURNAL OF NUTRITION (2011)
Treatment of Irritable Bowel Syndrome With Saccharomyces boulardii
Mario Guslandi
JOURNAL OF CLINICAL GASTROENTEROLOGY (2011)
A Randomized, Double-blind, Placebo-controlled Multicenter Trial of Saccharomyces boulardii in Irritable Bowel Syndrome Effect on Quality of Life
Chang Hwan Choi et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2011)
Clinical efficacy of Saccharomyces boulardii or metronidazole in symptomatic children with Blastocystis hominis infection
Ener Cagri Dinleyici et al.
PARASITOLOGY RESEARCH (2011)
Saccharomyces boulardii Improves Intestinal Cell Restitution through Activation of the α2β1 Integrin Collagen Receptor
Alexandra Canonici et al.
PLOS ONE (2011)
Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment
H. Szajewska et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Safety of probiotics in patients receiving nutritional support: a systematic review of case reports, randomized controlled trials, and nonrandomized trials
Kevin Whelan et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2010)
Preventive Effects of Different Probiotic Formulations on Travelers' Diarrhea Model in Wistar Rats Preventive Effects of Probiotics on TD
Jean-Francois Bisson et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Recent advances in Saccharomyces boulardii research
E. Im et al.
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE (2010)
Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
Stuart H. Cohen et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2010)
Probiotics and the gut microbiota in intestinal health and disease
Melanie G. Gareau et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
Systematic review and meta-analysis of Saccharomyces boulardii in adult patients
Lynne V. McFarland
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Regulatory Oversight and Safety of Probiotic Use
Veena Venugopalan et al.
EMERGING INFECTIOUS DISEASES (2010)
A randomized, open trial evaluating the effect of Saccharomyces boulardii on the eradication rate of Helicobacter pylori infection in children
Victoria Hurduc et al.
ACTA PAEDIATRICA (2009)
Saccharomyces boulardii for treating acute gastroenteritis in children: updated meta-analysis of randomized controlled trials
H. Szajewska et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Review article: anti-inflammatory mechanisms of action of Saccharomyces boulardii
C. Pothoulakis
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
PROBIOTIC GASTROINTESTINAL ALLERGIC REACTION CAUSED BY SACCHAROMYCES BOULARDII
Jin-Bok Hwang et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2009)
Saccharomyces boulardii inhibits lipopolysaccharide-induced activation of human dendritic cells and T cell proliferation
S. Thomas et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Twenty-Five Years of Research on Saccharomyces boulardii Trophic Effects: Updates and Perspectives
Jean-Paul Buts
DIGESTIVE DISEASES AND SCIENCES (2009)
The Effect of Saccharomyces boulardii on Human Colon Cells and Inflammation in Rats with Trinitrobenzene Sulfonic Acid-Induced Colitis
Sang Kil Lee et al.
DIGESTIVE DISEASES AND SCIENCES (2009)
Saccharomyces boulardii in childhood
Yvan Vandenplas et al.
EUROPEAN JOURNAL OF PEDIATRICS (2009)
Effects of yeast probiotic formulation on viability, revival and protection against infection with Salmonella enterica ssp enterica serovar Typhimurium in mice
F. S. Martins et al.
LETTERS IN APPLIED MICROBIOLOGY (2009)
Effects of Saccharomyces boulardii on cytokine secretion from intraepithelial lymphocytes infected by Escherichia coli and Candida albicans
Isil Fidan et al.
MYCOSES (2009)
The effect of Saccharomyces boulardii on reducing irinotecan-induced intestinal mucositis and diarrhea
Atakan Sezer et al.
MEDICAL ONCOLOGY (2009)
Unraveling the causes of negative studies: a case of S boulardii for the prevention of antibiotic-associated diarrhea
Lynne V McFarland
REVISTA MEDICA DE CHILE (2009)
Gastrointestinal microbiota in irritable bowel syndrome: Their role in its pathogenesis and treatment
Gareth C. Parkes et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Saccharomyces boulardii interferes with Shigella pathogenesis by postinvasion signaling events
Karen L. Mumy et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
Saccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factors
X. Wu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
Molecular analysis of the digestive microbiota in a gnotobiotic mouse model during antibiotic treatment:: Influence of Saccharomyces boulardii
Marie-Claude Barc et al.
ANAEROBE (2008)
Formulations for protecting the probiotic Saccharomyces boulardii from degradation in acidic condition
Sandrine Graff et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2008)
Biostructure of fecal microbiota in healthy subjects and patients with chronic idiopathic diarrhea
Alexander Swidsinski et al.
GASTROENTEROLOGY (2008)
Recommendations for probiotic use - 2008
Martin H. Floch et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2008)
Influence of pH conditions on the viability of Saccharomyces boulardii yeast
Sandrine Graff et al.
JOURNAL OF GENERAL AND APPLIED MICROBIOLOGY (2008)
Rapid determination of the bacterial composition of commercial probiotic products by terminal restriction fragment length polymorphism analysis
Angela Marcobal et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2008)
ESPGHAN/ESPID evidence-based guidelines for the management of acute gastroenteritis in children in Europe - Foreword
Alfredo Guarino
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2008)
Influence of Saccharomyces boulardii on the intestinal permeability of patients with Crohn's disease in remission
Eduardo Garcia Vilela et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2008)
Meta-analysis of probiotics for the treatment of irritable bowel syndrome
Lynne V. McFarland et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota
K. Kajander et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Effective prophylaxis against rotavirus diarrhea using a combination of Lactobacillus rhamnosus GG and antibodies
Neha Pant et al.
BMC MICROBIOLOGY (2007)
Yeast as probiotics - Saccharomyces boulardii
D. Czerucka et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations
Roberto Berni Canani et al.
BMJ-BRITISH MEDICAL JOURNAL (2007)
Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy:: A prospective randomized placebo-controlled double-blind study
Mehmet Cindoruk et al.
HELICOBACTER (2007)
Saccharomyces boulardii in acute childhood diarrhoea:: a randomized, placebo-controlled study
Gladys Villarruel et al.
ACTA PAEDIATRICA (2007)
Meta-analysis:: Saccharomyces boulardii for treating acute diarrhoea in children
H. Szajewska et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Meta-analysis:: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy
J. L. Tong et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Saccharomyces boulardii inhibits inflammatory bowel disease by trapping T cells in mesenteric lymph nodes
Guillaume Dalmasso et al.
GASTROENTEROLOGY (2006)
Saccharomyces boulardii inhibits ERK1/2 mitogen-activated protein kinase activation both in vitro and in vivo and protects against Clostridium difficile toxin A-induced enteritis
Xinhua Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Role of a probiotic (Saccharomyces boulardii) in management and prevention of diarrhoea
A. G. Billoo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Saccharomyces boulardii and infection due to Giardia lamblia
Bulent A. Besirbellioglu et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2006)
Saccharomyces boulardii produces in rat small intestine a novel protein phosphatase that inhibits Escherichia coli endotoxin by dephosphorylation
JP Buts et al.
PEDIATRIC RESEARCH (2006)
Saccharomyces boulardii prevents TNF-α-induced apoptosis in EHEC-infected T84 cells
Guillaume Dalmasso et al.
RESEARCH IN MICROBIOLOGY (2006)
Probiotics in gastrointestinal diseases in children: Hard and not-so-hard evidence of efficacy
Hania Szajewska et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2006)
Saccharonzyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-κB-mediated IL-8 gene expression
S Sougioultzis et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease
LV McFarland
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
The effects of Saccharomyces boulardii on bacterial translocation in rats with obstructive jaundice
Mehmet Faruk Geyik et al.
ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND (2006)
Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacter pylori eradication
DG Duman et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2005)
Inducible nitric oxide synthase involvement in the mechanism of action of Saccharomyces boulardii in castor oil-induced diarrhoea in rats
P Girard et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2005)
Effects of Saccharomyces boulardii on fecal short-chain fatty acids and microflora in patients on long-term total enteral nutrition
Stephane M. Schneider et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Meta-analysis:: non-pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea
H Szajewska et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Culture-dependent and culture-independent qualitative analysis of probiotic products claimed to contain bifidobacteria
L Masco et al.
INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY (2005)
Screening of yeasts as probiotic based on capacities to colonize the gastrointestinal tract and to protect against enteropathogen challenge in mice
FS Martins et al.
JOURNAL OF GENERAL AND APPLIED MICROBIOLOGY (2005)
Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children:: a randomized double-blind placebo-controlled trial
M Kotowska et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Saccharomyces boulardii induced sepsis: Successful therapy with voriconazole after treatment failure with fluconazole
O Burkhardt et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2005)
Effects of Saccharomyces boulardii in children with acute diarrhoea
Z Kurugol et al.
ACTA PAEDIATRICA (2005)
Effects of antibiotics and Saccharomyces boulardii on bacterial translocation in burn injury
O Herek et al.
SURGERY TODAY (2004)
Efficacy of saccharomyces boulardii with antibiotics in acute amoebiasis
F Mansour-Ghanaei et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2003)
A pilot trial of Saccharomyces boulardii in ulcerative colitis
M Guslandi et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2003)
Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cells
S Dahan et al.
INFECTION AND IMMUNITY (2003)
Experimental effects of Saccharomyces boulardii on diarrheal pathogens
D Czerucka et al.
MICROBES AND INFECTION (2002)
Inhibition of in vitro cell adherence of Clostridium difficile by Saccharomyces boulardii
A Tasteyre et al.
MICROBIAL PATHOGENESIS (2002)
Enterohemorrhagic Escherichia coli infection induces interleukin-8 production via activation of mitogen-activated protein kinases and the transcription factors NF-κB and AP-1 in T84 cells
S Dahan et al.
INFECTION AND IMMUNITY (2002)
Saccharomyces boulardii enhances N-terminal peptide hydrolysis in suckling rat small intestine by endoluminal release of a zinc-binding metalloprotease
JP Buts et al.
PEDIATRIC RESEARCH (2002)
Antibiotic-associated diarrhea
JG Bartlett
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice
A Qamar et al.
INFECTION AND IMMUNITY (2001)
Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea
L Kyne et al.
LANCET (2001)
The search for a better treatment for recurrent Clostridium difficile disease:: Use of high-dose vancomycin combined with Saccharomyces boulardii
CM Surawicz et al.
CLINICAL INFECTIOUS DISEASES (2000)
Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells
D Czerucka et al.
INFECTION AND IMMUNITY (2000)
Saccharomyces boulardii in maintenance treatment of Crohn's disease
M Guslandi et al.
DIGESTIVE DISEASES AND SCIENCES (2000)
Possible role of catheters in Saccharomyces boulardii fungemia
C Hennequin et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2000)
Probiotics and gastrointestinal health
SL Gorbach
AMERICAN JOURNAL OF GASTROENTEROLOGY (2000)
Saccharomyces boulardii stimulates slgA production and the phagocytic system of gnotobiotic mice
ACP Rodrigues et al.
JOURNAL OF APPLIED MICROBIOLOGY (2000)
Application of the colon-simulation technique for studying the effects of Saccharomyces boulardii on basic parameters of porcine cecal microbial metabolism disturbed by clindamycin
G Breves et al.
DIGESTION (2000)
分享论文
